fibroblast cell therapy (Cell Genesys (Somatix))

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namefibroblast cell therapy (Cell Genesys (Somatix))
Drug Alias NameL-aromatic acid decarboxylase gene therapy (Cell Genesys)tyrosine hydroxylase gene therapy (Cell Genesys)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionTyrosine 3-hydroxylase modulators
TargetsTyrosine 3-hydroxylase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSomatix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSomatix IncBiosante Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A